InsidersTradesSigma
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
No signal scores available.
Discover the detailed record of transactions filed by Farazi Paymon. Director active across 1 company, notably Signify Health, Inc.. In total, 4 disclosures have been logged. History available since 3 August 2022. The latest transaction was disclosed on 27 February 2023 (Attribution). Regulator: SEC (Form 4). All data is accessible without signup.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
4 of 4 declarations
Farazi Paymon is a declarant linked to Signify Health, Inc. (XNAS), where the listed role is Chief Product Officer. The record shows 4 filings in total, and the sampled filings run from 2022-08-05 to 2023-03-29, with a modal transaction nature of Attribution; the buy and sell amounts observed in those sampled filings are EUR 0 and EUR 0.